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Abstract
Novel drug delivery is a great tool to deliver the drug at a specific site of 
action by the means of specific drug carrier like Solid-lipid Nanoparticles, Nano-
structured lipid carriers, lipid vesicles, liposomes, phytosomes and ethosomes. 
Every carrier used in novel drug delivery system to deliver the drug at targeted 
site requires some special formulation techniques. These techniques help the 
drug carrier to deliver the active drug at targeted site, by reducing the side-effect, 
minimizing the dose, increasing the absorption and increasing the efficacy of the 
drug. There is a recent upsurge to move “back to nature” for healing body ailments 
because the report states that conventional treatment cause various side effects to 
the human body after prolonged used. Various novel drug delivery vesicles/‘somes’ 
are being used for the delivery of phytoconstitutents to the targeted site of action. 
Phytosome is one of the more reliable and best option for the delivery of herbal 
constituent to the targeted site. The combination of Novel drug delivery with the 
transdermal route may be a good idea having fast and targeted delivery of drug. 
Many health challenges like skin diseases, skin burns, migraine, allergies, cardiac 
problems, diabetes and trauma like bone fracture could be easily managed by the 
combination of novel drug delivery and the transdermal route in future.
Keywords: novel drug delivery, Phytosomes, herbal products, trauma,  
lipid vesicles, trandermal route
1. Background
With the advent of civilization Human beings have demonstrated their depen-
dence on Nature and plant to fulfill all basic needs. In an eventuality of an infirmity, 
diseased situation or healing of body ailments the use the plant based remedies 
had been on the anvil. With the passing of time the knowledge of healing from 
natural resources developed into science of healing and was documented in India 
as Ayurveda. The other world event over had similar chronological developments 
that led to the validation of the traditional knowledge of healing, that strength of 
of herbal formulations for the treatment of disease and body ailments. Most of the 
herbal formulations are administered via oral route and are poorly absorbed due 
to hydrophobic behavior which leads to decreased bioavailability and increased 
systemic clearance. Repeated administration or dose increment is required to 
maintain the therapeutic efficacy thereby limiting the use of herbal medicines [1]. 
Commonly, the herbal medicines utilize crude powders, extracts be formulation 
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in accordance to the statutory compendia which might not be needed in large 
doses, limited route of drug administration but also could be less effective than the 
contemporary therapeutic formulations. The rapid progress of allopathic drug lead 
to its dominance in the therapeutic field. The various types of dosage form of allo-
pathic drugs are available to treat the disease conditions i.e. solid dosage form (tab-
lets, capsules, and powders), Liquid dosage form (syrup, suspension, and emulsion 
given by oral route and injectables given by parental route), and aerosols. Nausea, 
vomiting, and dizziness are some common side effects associated with these con-
ventional dosage forms of allopathic system. Major complications have come forth 
after prolonged use of these formulations. There has been a continuous research on 
reducing side effects experienced by the patients resulting in some advancement to 
such conventional dosage form. Novel Drug delivery System (NDDS) is one such 
area of drug research that focuses on the target specific site of action and to mini-
mize the side effects of the conventional dosage form. Nowadays, there has been a 
change in global trend from synthetic to natural medicine, which we can say “back 
to nature.” The efficiency of medicinal plant species, or herbal medicine, depends 
on the active molecules present since they provide synergistic action and thus 
enhance the therapeutic effectiveness. Research is being continuously carried out 
for the amalgamation of Novel drug delivery and phytoconstituents to ward off any 
prevalent side effects of NDDS in allopathic system of treatment after prolonged 
used [2].
There are many kinds of herbal medicines and supplements used worldwide. 
The global market of phytomedicines currently stands at over $60 billion annually. 
The sale of herbal medicines was expected 6.4% on an average annual growth rate 
in 2012 [3, 4] (Table 1).
It is widely accepted that 70–80% of people globally rely on natural resources for 
their treatment. In the year 2017 the American Botanical council accepted that the sale 
of herbal supplements increased by 7.7% in US (on basis of turnover of herbal market 
in 2016). Europe leads the chart owing to extensive R&D for herbal medicine owing 
to considerable increase in funding for research on herbal medicinal plants. America 
stands on second position in the global herbal medicine market and held 16.2% of 
market share in 2017. The consumption of herbal supplements in US was majorly used 
for the conditions such as heart stroke (48.7%), Cancer (43.1%), and arthritis (43%) 
announced by National center for biotechnology information in 2017. Asia Pacific 
stands on third position having a growth rate of 5.99% due to the adoption of tradi-
tional medicine by pharmaceutical companies, researchers, and policy maker [5].
Global herbal market
Market size (US$ billions) Percentage
European Union 28 45
Rest EU 2.4 4
ASEAN 10.8 19
Japan 9.8 16





Segmentation of global herbal market in 2012.
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The major players in global herbal medicine market are Arkopharma, Beovita, 
Hisimo Pharmaceuticals, Bayer AG, Schaper & Brummer Venus Pharma, and 
Arizona Natural products. Some key players in the industry involved in the produc-
tion of herbal medicine and supplements include Bio-Botanica Inc., Dabur Ltd., 
Guangzhu Pharma Co., Nature’s Answer, Inc., Sanjiu Medical & Pharmaceutical 
Co. Ltd. The high market demand and an upbeat market trend in favor of natural 
products are likely to boost the growth in the days to come [5].
Current drug market-mix contains numerous formulations based on medicinal 
plants and phytoconstituents. However the constant decree that the herbal formula-
tions lack proper standardization protocols and is less efficacious or require larger dose 
to show its efficacy has deprived the impetus to become the alternative treatment regi-
men. Application of recent technological advancements such as amalgamation of novel 
drug delivery with herbal drugs would augment the efficacy of the traditional system.
Various approaches for improving bioavailability of novel herbals formulations 
followed as under [6–8]:
• Chemical derivatization to improve bioavailability which, however, generates a 
number of chemical analogs that need to be appropriately screened.
• Combination of the active molecules with other compounds as adjutants 
promoting the active molecule’s absorption.
• Stabilizing natural molecules and promotion of intestinal absorption.
• Improving pharmacokinetic profile by formulating with dietary ingredients 
(soy lecithin).
Many herbal formulations are being developed with the help of novel technolo-
gies of incorporation the phytoconstituents in the vesicles of lipid bi-layers. These 
vesicles work as novel carriers to deliver the drug at its targeted site. Some advanced 
drug delivery techniques use novel vehicles “somes” as nanobiomedicine delivered 
by different route of drug delivery. The novel carrier should ideally fulfill two pre-
requisites. Firstly, it should deliver the drug at predefined period of time or accord-
ing to the body requirements. Secondly, it should channel the active constituent to 
the site of action [9]. There are different types of novel drug vehicle as tabulated, 
use to deliver the drug molecules on the site of action (Table 2).
The nano-carrier used in novel drug delivery system of herbal drugs has a 
potential future, improving the activity and overcoming the problem associated 
with herbal constituents [10]. Any type of medicament could be delivered to its 
specific site of action with the help of novel drug delivery system. Researchers are 
• Liposomes • Nanoparticles and microspheres
• Niosomes • Solid lipid nanoparticles
• Hydrogel nanoparticles • Microparticles
• Resealed erythrocytes • Supramolecular biovectors
• Lipoproteins • Cyclodextrins
• Polymeric micelles • Aquasomes
• Dendrimers • Emulsions
Table 2. 
Different types of novel drug delivery systems [10].
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currently underway to develop an ideal drug delivery system which satisfies the 
need of targeted site of action. Biological membrane presents a barrier through 
which a drug must pass before it gets absorbed or excreted. Lipid solubility and 
molecular size of drug molecule pose two major limiting factors to pass the biologi-
cal membrane by which drug can be absorbed systematically following oral or 
topical administration [11].
The conventional herbal dosage form has a problem of standardization and 
quality control which had relegated its usage in the in last few decades. When the 
side effects of allopathic drugs outweigh their risk to usage the focus for treatment 
shifts towards the natural components and herbal system of treatment. In herbal 
novel drug development polymeric nanoparticles and nanocapsules like liposomes, 
solid lipid nanoparticles, phytosomes and nanoemulsion are been formulated. 
NDDS provides many advantages for herbal drugs including enhancement of 
solubility and bioavailability, protection from toxicity, enhancement of stability, 
enhancement of pharmacological action, improving tissue macrophages distribu-
tion, sustained delivery, and protection from physical and chemical degradation. 
The efficacy of herbal product (or medication) is dependent upon effective route of 
delivery and level of the active compounds [12].
Novel drug delivery systems deliver the drug components at a rate directed by 
the need of the body during the period of treatment and channelize the active entity 
onto the site of action. A number of novel drug delivery systems have been used 
to deliver herbal medicaments encompassing various routes of administration to 
achieve controlled and targeted drug delivery, for example, encapsulated vesicles 
can prolong the existence of the drug in systemic circulation and reduce the toxicity 
if selective uptake can be achieved through drug targeting, sustained or controlled 
release of conventional medicines [11, 12].
The novel drug delivery vehicles can be classified on the basis of their size, 
shape, and their composition (Table 3).
1.1 Liposomes
Liposomes are micro-sized spheres in which an aqueous core is surrounded by one 
or more lipid bi-layer. The lipid bi-layers are separated by water or aqueous buffer 
compartments, liposomes are simple microscopic vesicles in which aqueous volume is 
entirely enclosed by a membrane composed of lipid bilayers [13] (Figure 1).




Resealed erythrocytes [14] 6–9 μm (diameter)/oval Plasma, protein and platelets
Niosomes [15] 100–140 nm (diameter)/
spherical
Non-ionic surfactants and cholesterol
Discomes [16] 16–20 μm/disc shaped vesicles Cholesterol and niosomes
Transferosomes [17] 170–200 nm/oval Soya phophatidylcholine surfactant 
and drug/antigen
Ethosomes [18] 50–100 nm/spherical Phospholipid and ethanol
Phytosomes [19, 20] 10–100 nm/spherical Phospholipid and herbal extract
Aquasome/hydrosomes 60–300 nm/circular Ceramics, carbon [21]
Table 3. 
Classification of herbal novel drug delivery approach on the basis of their size, shape, and composition.
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1.2 Niosomes
Niosomes are non-ionic surfactant-based liposomes. Niosomes can be obtained 
by hydration of liposomes. These are microscopic lamellar structures formed 
upon combining non-ionic surfactant of the alkyl or dialkyl polyglycerol ether 
class with cholesterol [15]. The stability of niosomes are affected by type of 
surfactant, nature of encapsulated drug, storage temperature, detergents, use of 
membrane spanning lipids, the interfacial polymerization of surfactant mono-
mers in situ, inclusion of charged molecule. Niosomes have great penetrating 
capability [23] (Figure 2).
The sizes of Niosomes are microscopic and lie in nanometric scale. The particle 
size ranges from 10 to 100 nm [24].
Figure 1. 
Liposome (source: http://healthproductdistributor.com) [22].
Figure 2. 
Structure of niosome [24].
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1.3 Discomes
Discomes (disc shaped vesicles) are large (16–20 μm) sized vesicles structures 
capable of entrapping water soluble solutes, formed by solubilization of niosomes with 
a nonionic surfactant. They act as drug reservoirs in the field of drug delivery [16].
1.4 Transferesome
Transferosomes are complex vesicular aggregate optimized to attain extremely 
flexible and self-regulating membrane; this makes the vesicles very deformable. 
Transferosome have the property to cross microporous barrier very efficiently, 
even when available passage are much smaller than the average aggregate size. 
Transferosome consists of natural amphipathic compound suspended in water-
based solution, something containing biocompatible surfactant. Transferosome 
also have lipid bilayer that surrounds an aqueous core and contain at least one 
component that soften the membrane and make skin more flexible. This allows an 
easy and rapid change in shape of transferosome [17].
1.5 Ethosomes
Ethosomes are lipid vesicles containing high amount of ethanol. They have the 
efficiency to penetrate the skin and enhance compound delivery both to deep skin 
strata and systemically. Ethanol fluidizes both lipid bilayers of the stratum corneum 
and intercellular lipid. The soft malleable vesicles then penetrate the disorganized 
lipid bilayer. This system consists of phospholipid, ethanol and water [18].
1.6 Resealed erythrocytes
The fluid portion of blood contains a large number of organic and inorganic 
substances in solution, which may diffusible (electrolyte, anabolic and catabolic 
substance formed during metabolism) and non-diffusible (proteins). The cellular 
portion of blood consists of erythrocytes (red blood cells), leukocytes (white blood 
cells) and thrombocytes (platelets). Erythrocytes have a solid content of about 35% 
(rest of being water) most of which is hemoglobin, which is remain tightly bound 
to the stroma of cell membrane [14]. Resealed erythrocytes are drug-loaded carrier 
erythrocytes, prepared simply by collecting blood samples from the organism of 
interest, separating erythrocytes from plasma, entrapping drug in the erythrocytes, 
and resealing the resultant cellular carriers. Hence, these carriers are called resealed 
erythrocytes [14].
1.7 Aquasomes
Aquasomes are the nano-structured biopharmaceutical vesicles based upon 
fundamental principle of self-assembling. It contains the particle core composed 
of nano-crystalline calcium phosphate or ceramic diamond, and is covered by a 
polyhydroxyl oligomeric film. Aquasomes are also called as “bodies of water”. The 
drug candidates/molecule delivered by Aquasomes represent better biological 
activity even in case of conformationally sensitive ones. Aquasome having proper-
ties like protection and preservation of fragile biological molecules, conformational 
integrity, and surface exposure made it as a successful carrier system for bioactive 
molecules like peptide, protein, hormones, antigens and genes to specific sites [21].
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1.8 Phytosomes
Phytosomes is the combination of two words, the term “PHYTO” means plant 
while “SOME” means cell-like [25]. The formulation is developed by encapsulat-
ing the plant material or plant extract within the spherical cell like structure, 
which is an advanced nano-sphere or cell forms of herbal products that are better 
absorbed. Phytosomes produces better pharmacokinetic and pharmacodynamic 
profile of drug than conventional herbal formulations. It’s a novel emerging 
technique that is applied to phytopharmaceuticals for the enhancement of bio-
availability of natural plant extract for medicinal applications. Phytomedicines, 
complex chemical mixture prepared from plants, have been used in India and 
worldwide from the very beginning of human civilization and continue to have 
widespread popular use [26].
Phytosome is a patented process developed by Indena, a leading supplier 
of nutraceutical ingredients, to incorporate phospholipids into standardized 
extract and so vastly improve their absorption and utilization. Phytosome is 
one kind of herbal extracts delivery system that deliver natural values at target 
site in such manner. Certain of the water-soluble phytomolecules (mainly 
flavonoids and other polyphenols) can be converted into lipid-friendly com-
plexes, by reacting herbal extract owing to their enhanced capacity to cross 
the lipid-rich biomembranes and finally reach the blood. They have improved 
pharmacokinetic and pharmacological parameters which are advantageous 
in the treatment of acute disease as well as in pharmaceutical and cosmetic 
 compositions [19].
Phytosomes are better able making transition from a hydrophilic environment 
into the lipid-friendly environment of the enterocyte cell membrane and from there 
into the cell, finally reaching the blood. The lipid- phase substances employed to 
make flavonoids lipid- compatible are phospholipids from soy, mainly phospha-
tidylcholine (PC). PC, the principal molecular building block of cell membranes, 
is miscible both in water and in oil/lipid environments and is well absorbed when 
taken by mouth. Precise chemical analysis indicates that a Phytosome is usually a 
hydrophilic herbal extract linked with at least one PC molecule. A bond is formed 
between the two molecules, creating a hybrid molecule. This highly lipid-miscible 
hybrid bond is better suited to merge into the lipid phase of the enterocyte outer 
cell membrane [19].
2. Difference between phytosome and liposome
The fundamental difference between liposomes and Phytosomes is that in 
liposomes the active principle is dissolved in the medium contained in the cavity or 
in the layers of the membrane, whereas in the Phytosome it is an integral part of the 
membrane, being the molecules anchored through chemical bonds to the polar head 
of the phospholipid [20].
There may be hundreds or even thousands of phosphatidylcholine molecules 
surrounding the water soluble compound in Liposome. In contrast, the Phytosome 
contain Phosphatidylcholine and the individual plant components actually form 
a 1:1 or a 2:1 complex depending on the substance. This difference show that 
Phytosomes being much better absorbed than liposomes. Phytosomes are superior 
to liposomes in skin care products [27, 28] (Figure 3).
Phytosome (lower segment) liposome (upper segment).
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3. Merits of phytosomes over conventional dosage forms
• The bioavailability of botanical extracts enhanced dramatically due to their 
complexation with phospholipids by which absorption of the constituent 
improved in the intestinal tract [27–30].
• Phytosme enhances the permeation of non- lipophilic botanical extract to 
allow better absorption from the intestinal lumen, which not possible by other 
carriers.
• The formulation aspect of phytosome is safe and all active components have 
been approved for pharmaceutical and cosmetics use.
• Due to high Bioavailability, Phytosome is being used to deliver liver protecting 
Flavonoids.
• This technology offers cost effective delivery of Phytoconstituents to various 
targeted site for pharmacological action. Phytosomes produce synergistic ben-
efits when used as functional cosmetics, to protect the skin against exogenous 
or endogenous hazards in normal as well as stressful environment.
• They can be also used for enhancing permeation of drug, through skin in 
transdermal drug delivery system.
• They can be widely used in cosmetics due to their improved skin penetration 
and have a high lipid profile.
• Phosphatidylcholine, an essential part of the cell membrane and active com-
ponents in phytome, act as a carrier and nourish the skin. There is no problem 
with drug entrapment during formulation development. The drug entrapment 
efficiency with phytsome is high and more over predetermined; because the 
drug itself forms vesicles after conjugation with lipid.
• They offer a better stability profile because chemical bonds are formed 
between the phosphatidylcholine molecules and phytoconstituents.  
Figure 3. 
Difference between phytosome and liposome [29].
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The phytosomal system is passive, non-invasive and can is suitable for immedi-
ate commercialization.
• The dose requirement is reduced due to improved absorption of the main 
constituent. They can also be given in smaller quantities to achieve the desired 
therapeutic values.
• Low risk profile: This technology has no risk since the toxicological profiles of 
the phytosomal components are well documented in the scientific literature. 
Highly attractive market profile for products with proprietary technology. It is 
easy to formulate because no complicated technical investment required for the 
production of phytosomes.
4. Pharmaceutical scope of phytosome
• It enhances the absorption of lipid insoluble polar phytoconstituents through 
oral as well as topical route showing better bioavailability, so it has wide 
therapeutic benefits [28, 30].
• Appreciable drug entrapment.
• Phytosomes help to improve the absorption of active constituents and reduces 
the dose requirements.
• Phosphatidylcholine used in preparation of Phytosomes, besides acting as a 
carrier also acts as a hepatoprotective agent. Hence produce the synergistic 
effect to the liver targeted drug.
• Chemical bonds are formed between phosphatidylcholine molecule and 
phytoconstituent, this results better stability in Phytosome.
• Application of phytoconstituents in form of phytosome improves their 
percutaneous absorption and act as basic carrier for transdemal drug 
delivery.
5.  Phospholipids: creating the structural framework for novel drug 
delivery systems
These are complex substance having chemical, biochemical and nutritional 
characteristics by which they can distinguish as placed in a unique nutritional 
category. They are complex lipid molecules important for life and are found in all 
human and the other known structure to make cell membranes. The biochemical 
importance of phospholipids is reflected in their extraordinary clinical benefits 
as dietary supplements. The phospholipids are readily compatible with the entire 
range of vitamins, minerals, metabolites and herbal preparations. The dietary phos-
pholipids and omega-3 fatty acid works in functional synergy in cell membranes. 
Phosphatidylcholine is a bi-functional compound miscible both in water and in oil 
environments, and is well absorbed when taken by mouth. Phosphatidylcholine is 
not merely a passive “carrier” for the bioactive compounds, but is itself a bioactive 
nutrient with documented clinical efficacy for liver disease (including alcoholic 
hepatitis). Phosphatidylcholine is present in egg yolk, brain tissue and a wide 
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variety of animal fat and plant oils. It is routinely present in the bile fluid, to help 
emulsify food ingredient for absorption [31] (Figure 4).
A number of drug delivery system is based entirely on Phosphatidylcholine such 
as liposomes, ethosomes, phytosomes, transferosomes, and nanocochhelates. The 
hydrophilic and hydrophobic domain/segment within the molecular geometry of 
amphiphilic lipids orient and self-organize in ordered supramolecular structure 
when confronted with solvents. Some commonly used synthetic phospholipids 
are dioleoyl-phosphatidyl-choline (DOPC), dioleoyl-phosphatidyl-ethanolamine 
(DOPE), distearoyl-phosphatidyl-choline (DSPC), and distearoyl-phosphatidyl- 
ethanolamine (DSPE) [31].
6. Conjugation of NDDS with transdermal route
Transdermal drug delivery systems (TDDS) are topically administered 
medications in the form of patches, which can deliver certain medication to 
systemic circulation in a more convenient and effective way than is possible with 
conventional dosage form. The potential of skin as a path of drug administra-
tion has been amply demonstrated by the acceptability of marketed therapeutic 
systems [32]. Administration of systemic drugs using a transdermal patch 
represents a noninvasive route, with improved patient compliance. This route of 
administration prevents passage through the gastrointestinal tract and maintains 
constant plasma levels for prolonged periods of time [33]. A transdermal patch is 
a medicated adhesive patch placed on the skin to deliver a time-released dose of 
medication through the skin for treating topical or systemic illness. Since early 
1990, this dosage form of transdermal therapeutic system has been available in 
the pharmaceutical market. Such a system offers a variety of significant clinical 
benefits over others, such as tablet and injection [32, 33]. Transdermal route is a 
potential mode of delivery of lipophilic drugs in the systemic circulation. Some 
factors are responsible for transdermal drug delivery such as area of application, 
amount applied, release kinetics and prolongation of application time [34].
Figure 4. 
Cell membranes are largely lipid phase. A double molecular layer consisting of PC and other phospholipids 
provides a continuous matrix into which the proteins insert [31].
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7.  Feasibility of phytosome as novel vehicle for transdermal drug 
delivery
Lipophilic drugs could be easily transfused by transdemal route which 
enhance the bioavalibility of phytoconstitutent. Drug would be delivered into 
systemic circulation by transdermal route transdermal route. Drug has to pass 
three different skin layers before reaching to systemic circulation. The outermost 
layer, Stratum corneum provides hindrances to such type of drugs delivery due to 
its lipophilicity. The Phytosomal form of phytoconstituents can pass this barrier 
easily and helps to deliver the phytoconstituents in systemic circulation. The 
research studies from two decades show the phytosome technology has enough 
potency to be used as novel carrier of Phytoconstituents. Phytosomal carrier 
has enough potency to be used transdermally for increasing bioavailability of 
Phytoconstituents [34, 35].
8. Conclusion
Ever since the advent of human civilization, man is dependent on nature to 
fulfill all his need. Traditional system of healing human aliment was also derived 
from natural resources. In an era of development, devised various means of 
treatment primarily based on synthetic chemicals and popularly known as 
allopathic system of treatment. The inherent side effects of this system led to the 
shift in focus from contemporary to either conventional system of medication or 
to evolve the Novel drug delivery system. Novel drug delivery vehicles that can 
be used for the poorly soluble, pH sensitive and less potent drug to make them 
safe and target oriented. These novel drug delivery vehicles can also be utilized 
to deliver herbal formulations to its targeted site with lesser side effect. This 
phenomenon can be further augmented by conjugation of transdermal drug 
delivery system with novel drug delivery vehicle containing nanobiomedicine 
as herbal constituents. Phytosomes have shown the potential to be good carrier 
of herbal constituents for novel drug delivery systems. The combination of 
Transdermal route and Phytosomal drug delivery opens up an arena for better 
treatment for the patient suffering from skin diseases, Burn, allergies and bone 
fracture.
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